A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.

OBJECTIVE: To compare the potential of two diagnostic methods for detecting recurrence of urothelial cell carcinoma (UCC) of the bladder, by (i) detecting alterations in microsatellite DNA markers and loss of heterozygosity (LOH), and (ii) detecting aberrant gene hypermethylation, as UCC has a high...

Full description

Bibliographic Details
Main Authors:	Rouprêt, M, Hupertan, V, Yates, DR, Comperat, E, Catto, J, Meuth, M, Lackmichi, A, Ricci, S, Lacave, R, Gattegno, B, Richard, F, Hamdy, F, Cussenot, O
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

Molecular diagnosis of localized prostate cancer by quantitative methylation-specific PCR gene patterns in urine cells obtained by prostate massage
by: Roupret, M, et al.
Published: (2007)

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location
by: Catto, J, et al.
Published: (2007)

Clinically localised prostate cancer is microsatellite stable.
by: Azzouzi, A, et al.
Published: (2007)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

Behavior of urothelial carcinoma with respect to anatomical location.
by: Catto, J, et al.
Published: (2007)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
by: Roupret, M, et al.
Published: (2004)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
by: Yates, DR, et al.
Published: (2005)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
by: Rouprêt, M, et al.
Published: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
by: Roupret, M, et al.
Published: (2008)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
by: Catto, J, et al.
Published: (2009)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
by: Rouprêt, M, et al.
Published: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

The role of genetic instability in the pathogenesis and progression of urothelial carcinoma
by: Catto, J, et al.
Published: (2005)

Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
by: Rouprêt, M, et al.
Published: (2007)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
by: Dhawan, D, et al.
Published: (2006)

Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
by: Rouprêt, M, et al.
Published: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
by: Catto, J, et al.
Published: (2003)

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
by: Catto, J, et al.
Published: (2006)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
by: Rehman, I, et al.
Published: (2004)

[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
by: Burger, M, et al.
Published: (2006)

Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract
by: Burger, M, et al.
Published: (2006)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
by: Rehman, I, et al.
Published: (2004)

Diagnostic ureteroscopy in CT urography-diagnosed upper tract urothelial carcinoma: delay in definitive treatment and increased intravesical recurrence
by: Shsm, Hadi, et al.
Published: (2021)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
by: Catto, J, et al.
Published: (2003)

Urethral recurrence after radical cystectomy for urothelial carcinoma: a systematic review and meta-analysis
by: Fahmy Ahmed, Omar Ahmed, et al.
Published: (2018)

Artificial intelligence re-analysis of gene array data identifies novel markers of urothelial cancer progression
by: Catto, J, et al.
Published: (2007)

A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: implications for the COVID19 pandemic and beyond
by: Leow, Jeffrey J., et al.
Published: (2023)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
by: Rehman, I, et al.
Published: (2005)

Immunohistochemical analysis of homeobox protein expression in urothelial carcinoma of bladder
by: Md Akhir, Mohd Khairul Anuar
Published: (2016)

Genetic instability and transitional cell carcinoma of the bladder.
by: Catto, J, et al.
Published: (2004)

Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward. Eur Urol 2010; 57: 407-8
by: Catto, J, et al.
Published: (2010)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
by: Yates, DR, et al.
Published: (2006)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
by: Yates, DR, et al.
Published: (2006)

The urine output definition of acute kidney injury is too liberal
by: Md Ralib, Azrina, et al.
Published: (2013)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
by: Yates, D, et al.
Published: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
by: van Oers, J, et al.
Published: (2009)

Recurrence of Dupuytren's contracture: A consensus-based definition
by: Kan, HJ, et al.
Published: (2017)

Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis
by: Patel, Vaibhav, et al.
Published: (2017)